Memantine monotherapy is effective and safe for the treatment of mild to moderate Alzheimer's disease: A randomized controlled trial

被引：0
|
作者：
Peskind, E. R.
Potkin, S. G.
Pomara, N.
Ott, B. R.
McDonald, S.
Xie, Y.
Gergel, I.
机构：
[1] Univ Washington, Alzheimers Dis Res Ctr, Seattle, WA 98195 USA
[2] Univ Calif Irvine, Sch Med, Dept Psychiat, Irvine, CA 92717 USA
[3] Nathan S Kline Inst Psychiat Res, New York, NY USA
[4] NYU, Sch Med, New York, NY USA
[5] Brown Univ, Sch Med, Providence, RI 02912 USA
[6] Forest Res Inst, Jersey City, NJ USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2004年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：187 / 187
页数：1
相关论文
共 50 条
  • [1] Memantine monotherapy is effective and safe for the treatment of mild to moderate Alzheimer's disease: A randomized controlled trial
    Peskind, ER
    Potkin, SG
    Pomara, N
    Ott, BR
    McDonald, S
    Xie, Y
    Gergel, I
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S207 - S207
  • [2] Memantine monotherapy is effective and safe for the treatment of mild to moderate Alzheimer's disease: randomized, controlled trial
    Peskind, ER
    Potkin, SG
    Pomara, N
    Ott, BR
    McDonald, S
    Xie, Y
    Gergel, I
    ANNALS OF NEUROLOGY, 2004, 56 : S49 - S49
  • [3] Memantine monotherapy is effective and safe for the treatment of mild to moderate Alzheimer's disease: A randomized controlled trial
    Peskind, ER
    Potkin, SG
    Pomara, N
    Ott, BR
    McDonald, S
    Xie, Y
    Gergel, I
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S332 - S332
  • [4] Memantine, monotherapy is effective and safe for the treatment of mild to moderate Alzheimer's disease: A randomized controlled trial
    Pomara, N
    Peskind, ER
    Potkin, SG
    McDonald, S
    Xie, Y
    Gergel, I
    NEUROBIOLOGY OF AGING, 2004, 25 : S19 - S19
  • [5] Memantine treatment in mild to moderate Alzheimer disease: A 24-week randomized, controlled trial
    Peskind, Elaine R.
    Potkin, Steven G.
    Pomara, Nunzio
    Ott, Brian R.
    Graham, Stephen M.
    Olin, Jason T.
    McDonald, Scott
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2006, 14 (08): : 704 - 715
  • [6] Memantine in the treatment of mild-to-moderate Alzheimer's disease
    Cosman, Kelly M.
    Boyle, Llsa L.
    Porsteinsson, Anton P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (02) : 203 - 214
  • [7] Acupuncture for patients with mild to moderate Alzheimer's disease: a randomized controlled trial
    Jia, Yujie
    Zhang, Xuezhu
    Yu, Jianchun
    Han, Jingxian
    Yu, Tao
    Shi, Jiangwei
    Zhao, Lan
    Nie, Kun
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2017, 17
  • [8] Acupuncture for patients with mild to moderate Alzheimer’s disease: a randomized controlled trial
    Yujie Jia
    Xuezhu Zhang
    Jianchun Yu
    Jingxian Han
    Tao Yu
    Jiangwei Shi
    Lan Zhao
    Kun Nie
    BMC Complementary and Alternative Medicine, 17
  • [9] Memantine treatment of cognitive symptoms in mild to moderate Alzheimer disease: Secondary analyses from a placebo-controlled randomized trial
    Pomara, Nunzio
    Ott, Brian R.
    Peskind, Elaine
    Resnick, E. Malca
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2007, 21 (01): : 60 - 64
  • [10] Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy
    Modrego, P. J.
    Fayed, N.
    Errea, J. M.
    Rios, C.
    Pina, M. A.
    Sarasa, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (03) : 405 - 412
12345